1. Home
  2. CPIX vs ROMA Comparison

CPIX vs ROMA Comparison

Compare CPIX & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • ROMA
  • Stock Information
  • Founded
  • CPIX 1999
  • ROMA 2018
  • Country
  • CPIX United States
  • ROMA Hong Kong
  • Employees
  • CPIX N/A
  • ROMA N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • ROMA Savings Institutions
  • Sector
  • CPIX Health Care
  • ROMA Finance
  • Exchange
  • CPIX Nasdaq
  • ROMA Nasdaq
  • Market Cap
  • CPIX 40.1M
  • ROMA 45.3M
  • IPO Year
  • CPIX 2009
  • ROMA 2024
  • Fundamental
  • Price
  • CPIX $3.15
  • ROMA $3.20
  • Analyst Decision
  • CPIX
  • ROMA
  • Analyst Count
  • CPIX 0
  • ROMA 0
  • Target Price
  • CPIX N/A
  • ROMA N/A
  • AVG Volume (30 Days)
  • CPIX 110.2K
  • ROMA 270.0K
  • Earning Date
  • CPIX 08-05-2025
  • ROMA 08-01-2025
  • Dividend Yield
  • CPIX N/A
  • ROMA N/A
  • EPS Growth
  • CPIX N/A
  • ROMA N/A
  • EPS
  • CPIX N/A
  • ROMA N/A
  • Revenue
  • CPIX $41,083,299.00
  • ROMA $1,029,120.00
  • Revenue This Year
  • CPIX N/A
  • ROMA N/A
  • Revenue Next Year
  • CPIX N/A
  • ROMA N/A
  • P/E Ratio
  • CPIX N/A
  • ROMA N/A
  • Revenue Growth
  • CPIX 5.82
  • ROMA N/A
  • 52 Week Low
  • CPIX $1.04
  • ROMA $0.46
  • 52 Week High
  • CPIX $7.25
  • ROMA $4.14
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 37.09
  • ROMA 58.38
  • Support Level
  • CPIX $2.52
  • ROMA $2.91
  • Resistance Level
  • CPIX $3.76
  • ROMA $3.44
  • Average True Range (ATR)
  • CPIX 0.59
  • ROMA 0.29
  • MACD
  • CPIX -0.14
  • ROMA -0.01
  • Stochastic Oscillator
  • CPIX 19.39
  • ROMA 72.73

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About ROMA Roma Green Finance Limited

Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage and overcome various business matters arising from such factors related to ESG, sustainability and climate change. it provides tailored-made sustainability solutions to meet the client's specific needs. Its mission is to provide its clients with a one-stop destination for high-quality and holistic sustainability and climate change-related consulting services to support a more sustainable, balanced and inclusive future for its clients' organizations and the world.

Share on Social Networks: